Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement regulatory proteins in glomerular diseases

M Nangaku1

  • 1Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan. mnangaku-tky@umin.ac.jp

Kidney International
|December 9, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Starvation in the Midst of Plenty? The Role of Hypoxia in Progression: Hypoxia in Renal Disease with Proteinuria and/or Glomerular Hypertension. Am J Path 265: 1979-1992, 2004.

Journal of the American Society of Nephrology : JASN·2023
Same author

Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis.

Scandinavian journal of rheumatology·2021
Same author

Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Enarodustat to treat anemia in chronic kidney disease.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

Primary bone adult T cell lymphoma with multiple skeletal lesions and debilitating painful osteolysis: a case report.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Stimulatory effect of insulin on H+-ATPase in the proximal tubule via the Akt/mTORC2 pathway.

Physiology international·2020

Complement regulatory proteins protect the glomerulus from injury in glomerulonephritis. Therapeutic strategies like protein administration and overexpression show promise for treating kidney disease.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Complement activation is a key driver in glomerulonephritis pathogenesis, causing tissue damage via chemotactic factors and C5b-9 insertion.
  • Complement regulatory proteins (CRPs) like DAF, MCP, CR1, and CD59 control complement activation.
  • These proteins, particularly membrane-bound CRPs, are abundant in the glomerulus and protect against immune-mediated renal injury.

Purpose of the Study:

  • To review the role of complement regulatory proteins in glomerulonephritis.
  • To discuss the mechanisms of action and regulation of CRPs in the glomerulus.
  • To explore novel therapeutic strategies for glomerulonephritis based on CRPs.

Main Methods:

  • Review of scientific literature on complement activation and regulation in glomerulonephritis.

Related Experiment Videos

  • Analysis of the expression and function of CRPs (DAF, MCP, CR1, CD59) in glomerular cells.
  • Evaluation of studies using cultured cells and animal models to assess CRP protective roles.

    • Main Results:

    • DAF, MCP, and CR1 inactivate C3/C5 convertase, while CD59 inhibits C5b-9 formation.
    • All three resident glomerular cells express DAF, MCP, and CD59; podocytes uniquely express CR1.
    • Altered CRP expression is observed in glomerular disorders, and studies indicate their protective function against renal injury.

    Conclusions:

    • Complement regulatory proteins play a crucial protective role in the glomerulus against immune-mediated injury.
    • Therapeutic strategies involving systemic administration of soluble CRPs or local overexpression are promising for glomerulonephritis treatment.